SALT LAKE CITY, May 23, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced seven new commercial coverage decisions for Prolaris ...
In a groundbreaking decision issued May 21, 2025, the Michigan Court of Appeals handed down a pivotal win for car crash victims across the state, particularly those injured by a negligent family ...
A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback